Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy

Medications
1

The drug can be administered at one- or two-month intervals. After it is dosed, therapeutic blood concentrations are reached in six to 24 hours, MedinCell said.

Risperdal

1 Like